<DOC>
	<DOCNO>NCT00287196</DOCNO>
	<brief_summary>This trial seek establish role post-operative radiotherapy patient surgery melanoma involve lymph node high risk recurrence .</brief_summary>
	<brief_title>Immediate Radiotherapy Observation After Surgery Melanoma Involving Lymph Nodes</brief_title>
	<detailed_description>This randomised phase III trial perform patient high risk local recurrence lymphadenectomy stage 3 melanoma . The control arm surgery alone radiotherapy reserved recur . The study arm surgery plus post-operative radiotherapy . All 3 major node site eligible . The radiation dose administer 48Gy 20 fraction . It likely study kind ever perform . The target 230 patient .</detailed_description>
	<mesh_term>Melanoma</mesh_term>
	<mesh_term>Lymphatic Diseases</mesh_term>
	<criteria>Regional macroscopic nodal metastatic melanoma one nodal basin region completely resect . melanoma involve lymph node high risk local recurrence ( detail protocol ) No evidence metastases No active major cancer within 5 year Normal blood test WHO performance status 0 1 Radiotherapy must able commence within 12 week lymphadenectomy Patient must pregnant fertile must use medically acceptable contraceptive throughout treatment No major concurrent illness likely cause death within 2 year Written inform consent give Evidence active previous local recurrence transit disease Evidence distant metastasis clinical radiological investigation Patients prior cancer</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>Melanoma</keyword>
	<keyword>Lymph node disease</keyword>
	<keyword>Adjuvant radiotherapy</keyword>
	<keyword>Lymphoedema</keyword>
</DOC>